BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
1849 Total Holdings:
As of 3/31/24
All Holdings:
1 -
15 of
1849
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Broadcom, Inc. | Equity | 3,401,949 | $4,508,977,224.00 | 4.25% |
| Capital Group Central Cash Fund | Short Term | 42,796,793 | $4,277,967,380.00 | 4.04% |
| Capital Group Central Corporate Bond Fund | Investment Fund | 298,028,896 | $2,491,521,568.00 | 2.35% |
| AbbVie, Inc. | Equity | 13,384,481 | $2,437,313,990.00 | 2.3% |
| Microsoft Corp. | Equity | 5,529,690 | $2,326,451,177.00 | 2.2% |
| Philip Morris International, Inc. | Equity | 24,367,173 | $2,232,520,390.00 | 2.11% |
| RTX Corp. | Equity | 18,567,940 | $1,810,931,188.00 | 1.71% |
| Abbott Laboratories | Equity | 13,707,205 | $1,557,960,920.00 | 1.47% |
| VICI Properties, Inc. REIT | Equity | 48,734,583 | $1,451,803,228.00 | 1.37% |
| Canadian Natural Resources, Ltd. | Equity | 17,967,234 | $1,370,605,950.00 | 1.29% |
| JPMorgan Chase & Co. | Equity | 6,265,993 | $1,255,078,398.00 | 1.18% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | Equity | 49,901,856 | $1,199,072,828.00 | 1.13% |
| Amgen, Inc. | Equity | 4,079,494 | $1,159,881,734.00 | 1.09% |
| Gilead Sciences, Inc. | Equity | 15,820,423 | $1,158,845,985.00 | 1.09% |
| Zurich Insurance Group AG | Equity | 2,033,340 | $1,096,427,612.00 | 1.03% |
All Holdings:
1 -
15 of
1849